Filing Details

Accession Number:
0001104659-20-080030
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-01 21:36:15
Reporting Period:
2020-06-30
Accepted Time:
2020-07-01 21:36:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1722271 Akouos Inc. AKUS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202793 Michael Powell 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1245624 James Healy 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1680194 Sofinnova Management X, L.l.c. 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1680200 Sofinnova Venture Partners X, L.p. 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1720685 Maha Katabi C/O Apellis Pharmaceuticals, Inc.
6400 Westwind Way, Suite A
Crestwood MA 40014
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-30 856,262 $0.00 856,262 No 4 C Direct
Common Stock Acquisiton 2020-06-30 599,988 $0.00 1,456,250 No 4 C Direct
Common Stock Acquisiton 2020-06-30 58,823 $17.00 1,515,073 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2020-06-30 18,044,028 $0.00 856,262 $0.00
Common Stock Series B Preferred Stock Disposition 2020-06-30 12,643,557 $0.00 599,988 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Upon the closing of the initial public offering of the Issuer's Common Stock, the Series A Preferred Stock automatically converted into Common Stock on a 21.073-for-1 basis without payment of further consideration. The shares of Series A Preferred Stock had no expiration date.
  2. The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.
  3. Upon the closing of the initial public offering of the Issuer's Common Stock, the Series B Preferred Stock automatically converted into Common Stock on a 21.073-for-1 basis without payment of further consideration. The shares of Series B Preferred Stock had no expiration date.